CERT

$0.00

(

0.00%

)
Quote details

stock

Certara Inc

NASDAQ | CERT

8.67

USD

$0.00

(

0.00%

)

At Close (As of Nov 7, 2025)

$1.81B

Market Cap

225.4

P/E Ratio

0.05

EPS

$15.69

52 Week High

$8.47

52 Week Low

HEALTHCARE

Sector

CERT Chart

Recent Chart
Price Action

CERT Technicals

Tags:

CERT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $231M
Total Revenue $385M
Cost Of Revenue $155M
Costof Goods And Services Sold $155M
Operating Income -$1.7M
Selling General And Administrative $94M
Research And Development $37M
Operating Expenses $232M
Investment Income Net -
Net Interest Income -$22M
Interest Income -
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $68M
Income Before Tax -$17M
Income Tax Expense -$5.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit $4.3M
Ebitda $72M
Net Income -$12M

Revenue & Profitability

Earnings Performance

CERT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.6B
Total Current Assets $311M
Cash And Cash Equivalents At Carrying Value $179M
Cash And Short Term Investments $179M
Inventory $1
Current Net Receivables $119M
Total Non Current Assets $1.3B
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $485M
Intangible Assets Excluding Goodwill $485M
Goodwill $757M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $516M
Total Current Liabilities $146M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $8.3M
Total Non Current Liabilities $370M
Capital Lease Obligations $16M
Long Term Debt $292M
Current Long Term Debt $3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $312M
Other Current Liabilities $56M
Other Non Current Liabilities $24M
Total Shareholder Equity $1.1B
Treasury Stock -
Retained Earnings -$128M
Common Stock $1.6M
Common Stock Shares Outstanding $160M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $80M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $68M
Capital Expenditures $1.6M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$112M
Cashflow From Financing -$21M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$6.4M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$12M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $231M
Total Revenue $385M
Cost Of Revenue $155M
Costof Goods And Services Sold $155M
Operating Income -$1.7M
Selling General And Administrative $94M
Research And Development $37M
Operating Expenses $232M
Investment Income Net -
Net Interest Income -$22M
Interest Income -
Interest Expense $22M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $68M
Income Before Tax -$17M
Income Tax Expense -$5.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit $4.3M
Ebitda $72M
Net Income -$12M

CERT News

CERT Profile

Certara Inc Profile

Sector: HEALTHCARE

Industry: HEALTH INFORMATION SERVICES

Certara Inc. (CERT) is a prominent provider of biosimulation software and technology services designed to enhance the efficiency of drug discovery, preclinical and clinical research, and regulatory compliance. Headquartered in Princeton, New Jersey, the company utilizes advanced modeling and simulation techniques to empower pharmaceutical companies in making data-driven decisions that facilitate faster market access for new therapies. With a steadfast commitment to innovation, Certara is dedicated to optimizing drug development pathways, ultimately aiming to improve patient outcomes in the evolving biopharmaceutical landscape.

BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ACHR
-7.88%
$8.18
ASST
+4.13%
$1.51
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
ONDS
+10.66%
$5.81
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
AAL
+3.80%
$13.65
BITF
-0.81%
$3.66
AXDX
-61.36%
$0.03
WTO
-7.52%
$0.04
SNAP
+2.49%
$8.21
RIVN
+0.06%
$15.23
NIO
-4.18%
$6.86
T
+0.36%
$24.83
DVLT
+24.26%
$1.69
CHR
+0.15%
$0.06
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BTG
+2.89%
$3.91
BURU
+3.54%
$0.28
JOBY
+4.05%
$14.90
IREN
-6.83%
$62.38
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
PBR
+5.93%
$12.86
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
YDKG
-1.56%
$0.05
AMZN
+0.56%
$244.41
BMNR
+7.65%
$40.22
HOOD
+2.58%
$130.36
CIFR
-4.69%
$20.69
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
BTBT
+3.63%
$3.14
EOSE
+19.42%
$18.26
DKNG
+8.64%
$30.40
SMR
-6.53%
$30.34
RMBL
+60.50%
$3.21
BAC
-0.16%
$53.20
RIG
+2.05%
$3.98
ABEV
+1.25%
$2.43
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
NOK
-0.72%
$6.86
GOOGL
+0.15%
$284.75
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
TTD
-6.31%
$43.00
ORGO
+44.73%
$5.63
QS
+4.52%
$16.62
SMCI
-1.42%
$39.76
CMG
+0.09%
$30.59
IONQ
+3.20%
$59.27
PLTZ
+13.94%
$7.11
EPWK
+3.23%
$0.07
FIG
-3.76%
$44.25
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.50%
$2.40
PTON
+14.15%
$7.66
RF
+2.22%
$24.85
IOVA
-0.43%
$2.29
ELDN
-49.75%
$2.06
MTC
-6.85%
$2.58
META
+0.44%
$621.71
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
CAN
+5.30%
$1.19
VZ
+0.55%
$40.04
QUBT
-2.20%
$12.86
NGD
+1.58%
$7.03
CLSK
+1.10%
$15.57
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36
PLTD
-1.59%
$6.78
BKYI
+51.56%
$0.96
RUBI
+39.37%
$0.31
AZI
-4.05%
$0.09
NVDA
+0.03%
$188.15
ACHR
-7.88%
$8.18
ASST
+4.13%
$1.51
BYND
+16.80%
$1.39
PFE
+0.04%
$24.43
PLUG
+5.57%
$2.65
MSGM
+70.77%
$3.74
TSLA
-3.67%
$429.52
ONDS
+10.66%
$5.81
INTC
+2.38%
$38.13
VHAI
0.00%
$0.00
GRAB
-1.24%
$5.56
F
+1.82%
$13.21
SOFI
+3.86%
$28.21
DNN
-0.39%
$2.54
PLTR
+1.64%
$177.93
AAL
+3.80%
$13.65
BITF
-0.81%
$3.66
AXDX
-61.36%
$0.03
WTO
-7.52%
$0.04
SNAP
+2.49%
$8.21
RIVN
+0.06%
$15.23
NIO
-4.18%
$6.86
T
+0.36%
$24.83
DVLT
+24.26%
$1.69
CHR
+0.15%
$0.06
ETHD
-9.69%
$4.38
RGTI
-1.71%
$33.77
BTG
+2.89%
$3.91
BURU
+3.54%
$0.28
JOBY
+4.05%
$14.90
IREN
-6.83%
$62.38
RXRX
0.00%
$4.62
PRMB
-18.30%
$14.46
AMD
-1.75%
$233.54
MARA
-0.56%
$15.87
ADAP
-15.14%
$0.05
QBTS
+3.90%
$29.50
PBR
+5.93%
$12.86
SOUN
-0.63%
$14.14
IONZ
-6.57%
$3.55
NVTS
-11.26%
$7.84
AAPL
-0.48%
$268.47
KVUE
+2.55%
$16.88
YDKG
-1.56%
$0.05
AMZN
+0.56%
$244.41
BMNR
+7.65%
$40.22
HOOD
+2.58%
$130.36
CIFR
-4.69%
$20.69
MTVA
+6.84%
$0.90
WULF
-2.38%
$13.94
BTBT
+3.63%
$3.14
EOSE
+19.42%
$18.26
DKNG
+8.64%
$30.40
SMR
-6.53%
$30.34
RMBL
+60.50%
$3.21
BAC
-0.16%
$53.20
RIG
+2.05%
$3.98
ABEV
+1.25%
$2.43
ADD
-25.47%
$0.05
TLRY
+2.47%
$1.24
NOK
-0.72%
$6.86
GOOGL
+0.15%
$284.75
GPUS
+0.43%
$0.37
SRM
+53.27%
$10.30
TTD
-6.31%
$43.00
ORGO
+44.73%
$5.63
QS
+4.52%
$16.62
SMCI
-1.42%
$39.76
CMG
+0.09%
$30.59
IONQ
+3.20%
$59.27
PLTZ
+13.94%
$7.11
EPWK
+3.23%
$0.07
FIG
-3.76%
$44.25
VALE
-0.65%
$12.15
WBD
+1.11%
$22.67
MU
-0.17%
$237.92
AMC
-7.50%
$2.40
PTON
+14.15%
$7.66
RF
+2.22%
$24.85
IOVA
-0.43%
$2.29
ELDN
-49.75%
$2.06
MTC
-6.85%
$2.58
META
+0.44%
$621.71
CGC
+7.33%
$1.17
HIMS
-1.18%
$41.03
WLGS
-5.57%
$0.04
BBD
+0.85%
$3.54
HBAN
+1.75%
$15.69
CAN
+5.30%
$1.19
VZ
+0.55%
$40.04
QUBT
-2.20%
$12.86
NGD
+1.58%
$7.03
CLSK
+1.10%
$15.57
ETWO
0.00%
$3.30
AMCR
+1.82%
$8.36
PLTD
-1.59%
$6.78

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.